Document is current

Article History

Received: 17 October 2023

Accepted: 7 March 2024

First Online: 20 March 2024

Declarations

:

: Ethical approval for this study was obtained from the Ethics Committee of the Autonomous Province of Bolzano on 09.08.2023 (protocol number 73–2023). Written informed consent was obtained from all participants before any trial-related procedures were performed. This includes consent for participation in the study, data sharing, and the publication of results. The consent process was conducted in accordance with the guidelines of the Ethics Committee.

: Model consent forms and related documentation are provided to study participants. These documents are designed to provide clear and accessible information regarding the study objectives, procedures, benefits, and potential risks. They also detail the confidentiality measures in place and the rights of the participants, including their right to withdraw from the study at any time, without any impact on their regular care. Written informed consent is obtained from all the participants to ensure that they fully understood all aspects of the study before any trial-related procedures is performed. If required, we would be willing to provide consent upon request.

: The authors declare that they have no competing interests that could have influenced the results or interpretations of this study. AHMG-S developed the ABCC tool at the University of Maastricht and has made it freely available for use with no restrictions or charges. Some of the salaries of CJW, AM, and VB are covered by the funds raised. These circumstances did not influence the study design or plans for data collection, analysis, or interpretation of results. All authors had full access to all data and took responsibility for the integrity and accuracy of the study protocol.